Rhelion Life Sciences Corp. (RHEL)
CSE
Closed
Sep 11, 2026
Day's Range
0.030052 wk Range
0.0250Overview - RHEL - Rhelion Life Sciences Corp.
Key Statistics
Valuation
Enterprise Value
12.50M
P/E (Trailing)
‪-2.21‬
Price / Sales (TTM)
‪5.21‬
Price / Book
‪1.16‬
EV / EBITDA
‪-2.88‬
Profitability
Gross Margin
‪91.22%‬
Profit Margin
‪-181.28%‬
Operating Margin
‪-774.50%‬
Return on Assets
‪-13.71%‬
Return on Equity
‪-41.31%‬
Ownership
Shares Outstanding
614.12M
Float
575.17M
Held by Insiders
‪5.90%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.96‬
50-Day Avg
‪0.0293‬
200-Day Avg
‪0.0274‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - RHEL - Rhelion Life Sciences Corp.
Peers - RHEL - Rhelion Life Sciences Corp.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on CSE.
- RHELCSERhelion Life Sciences Corp.19.95MMarket Cap+23.08%52-week change-2.22P/E (Trailing)‪-181.28%‬Profit Margin
- GTIICSEGreen Thumb Industries Inc.2.05BMarket Cap-30.18%52-week change12.73P/E (Trailing)‪10.48%‬Profit Margin
- GDNSCSEGoodness Growth Holdings, Inc.605.77MMarket Cap-74.79%52-week change-6.23P/E (Trailing)‪47.28%‬Profit Margin
- CLCSECresco Labs Inc.394.15MMarket Cap-77.36%52-week change-2.79P/E (Trailing)‪-15.49%‬Profit Margin
- JUSHCSEJushi Holdings Inc.185.71MMarket Cap-7.53%52-week change-2.66P/E (Trailing)‪-24.44%‬Profit Margin
- GRINCSEGrown Rogue International Inc.152.46MMarket Cap+1.64%52-week change59.00P/E (Trailing)‪-12.63%‬Profit Margin
- AAWH.UCSEAscend Wellness Holdings Inc.119.89MMarket Cap-23.73%52-week change-1.02P/E (Trailing)‪-23.30%‬Profit Margin
Profile Summary - RHEL - Rhelion Life Sciences Corp.
About
Rhelion Life Sciences Corp. is a life sciences company focused on the research, development, and commercialization of natural psychedelic medicines and related products. The company operates a pharmaceutical development platform through its subsidiary Filament Health, where it advances naturally derived psilocybin…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
